cytidine monophosphate has been researched along with Carcinoma, Hepatocellular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyer, SH; Craigo, W; Erion, MD; Esterbrook, J; Gómez-Galeno, JE; Jiang, H; MacKenna, DA; Reddy, KR; Sun, Z; Ugarkar, BG | 1 |
| Miyazawa, J; Sakata, Y; Suto, K; Suto, T; Watanabe, Y; Yoshida, Y | 1 |
| Chida, N; Ono, T; Oohira, H; Sakata, Y; Suto, T; Yamada, N; Yoshida, T; Yoshida, Y | 1 |
2 trial(s) available for cytidine monophosphate and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prodrugs; Tomography, X-Ray Computed | 1997 |
[Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].
Topics: Administration, Oral; Aged; Anemia; Anorexia; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Thrombocytopenia | 1998 |
1 other study(ies) available for cytidine monophosphate and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Prodrugs; Rats; Tissue Distribution | 2006 |